Prevalence, mechanisms, and management of cancer-related cognitive impairment (Q33854977)

29 July 2017

Prevalence, mechanisms, and management of cancer-related cognitive impairment (English)

1 reference

29 July 2017

cognitive dysfunction

1 reference

Michelle C Janelsins

1

1 reference

29 July 2017

Shelli R Kesler

series ordinal

2

1 reference

29 July 2017

Tim A Ahles

series ordinal

3

1 reference

29 July 2017

Gary R Morrow

series ordinal

4

1 reference

29 July 2017

language of work or name

1 reference

1 February 2014

1 reference

International Review of Psychiatry

29 July 2017

1 reference

29 July 2017

26

1 reference

29 July 2017

102-113

1 reference

29 July 2017

1

1 reference

Default mode network as a potential biomarker of chemotherapy-related brain injury

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Multivariate pattern analysis of FMRI in breast cancer survivors and healthy women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Tumor necrosis factor-alpha-converting enzyme activities and tumor-associated macrophages in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep problems, Depression, Pain, Anxiety, and Physical Dysfunction: A Review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Midlife obesity and dementia: meta-analysis and adjusted forecast of dementia prevalence in the United States and China

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Early changes in brain FDG metabolism during anticancer therapy in patients with pharyngeal cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive function and breast cancer: promise and potential insights from functional brain imaging

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cancer- and cancer treatment-associated cognitive change: an update on the state of the science

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Advanced cognitive training for breast cancer survivors: a randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Fruit, vegetables and prevention of cognitive decline or dementia: a systematic review of cohort studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Altered resting state functional brain network topology in chemotherapy-treated breast cancer survivors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Exercise and Cancer Treatment Symptoms in 408 Newly Diagnosed Older Cancer Patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Altered small-world properties of gray matter networks in breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Fluoxetine counteracts the cognitive and cellular effects of 5-fluorouracil in the rat hippocampus by a mechanism of prevention rather than recovery

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive function and quality of life in ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Prefrontal cortex and executive function impairments in primary breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Estrogen and cognitive functioning in women: lessons we have learned

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Breast cancer stem cells, cytokine networks, and the tumor microenvironment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Chemotherapy and cognitive impairment: treatment options

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

An update on cancer- and chemotherapy-related cognitive dysfunction: current status

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog').

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Self-reported cognitive impairment in patients with cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Metallothionein induction reduces caspase-3 activity and TNFalpha levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Regional brain activation during verbal declarative memory in metastatic breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Evaluating the dimensionality of perceived cognitive function.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

The effect of modafinil on cognitive function in breast cancer survivors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive effects of hormone therapy in men with prostate cancer: a review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive impairment with significant brain parenchymal volume loss following standard adjuvant chemotherapy in a patient with breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive function in breast cancer patients prior to adjuvant treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Mechanisms of cancer-related fatigue

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Candidate mechanisms for chemotherapy-induced cognitive changes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive-behavioral management of chemotherapy-related cognitive change

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Twenty years of research on cytokine-induced sickness behavior

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Management of cancer-related fatigue

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

The genetics of cognitive processes: candidate genes in humans and animals.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

5 July 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cognitive impairment associated with adjuvant therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Short-term effects of breast cancer on labor market attachment: results from a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cognitive functions in long-term survivors of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Effects of adjuvant treatment on cognitive function in women with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cognitive Dysfunction Following Adjuvant Chemotherapy for Breast Cancer: Two Case Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Stress, coping and cognitive deficits in women after surgery for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Tai Chi effects on neuropsychological, emotional, and physical functioning following cancer treatment: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Assessing cognitive function in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Predictors of cognitive decline after chemotherapy in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Serum cytokine in response to chemo-radiotherapy for Hodgkin's disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4084673

No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy

29 October 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.864260

Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24716504

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24716504

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24716504

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3109/09540261.2013.864260

1 reference

29 July 2017

1 reference

29 July 2017

1 reference